Articles published in Journal of Stem Cell Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Stem Cell Research & Therapy has got h-index 33, which means every article in Journal of Stem Cell Research & Therapy has got 33 average citations.

Following are the list of articles that have cited the articles published in Journal of Stem Cell Research & Therapy.

Journal total citations count 6793
Journal impact factor 1.64
Journal 5 years impact factor 1.70
Journal cite score 11.56
Journal h-index 33
Important citations

Self-renewal capacity of double negative 3 (DN3) early thymocytes preserves thymus autonomous function but compromises the ?-selection checkpoint

Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation

Human Pluripotent Stem Cells and CRISPR-Cas9 Genome Editing to Model Diabetes

Re-educating immunity in respiratory allergies: the potential for hematopoietic stem cell-mediated gene therapy

Towards safe therapy for immunodeficiency

Update on clinical ex vivo hematopoietic stem cell gene therapy for inherited monogenic diseases

Innovative cell-based therapies and conditioning to cure RAG deficiency

Gene replacement of ?-globin with ?-globin restores hemoglobin balance in ?-thalassemia-derived hematopoietic stem and progenitor cells

An integrated transcriptional switch at the ?-selection checkpoint determines T cell survival, development and leukaemogenesis

Laboratory-scale lentiviral vector production and purification for enhanced ex vivo and in vivo genetic engineering

Preclinical development of autologous hematopoietic stem cell-based gene therapy for immune deficiencies: A journey from mouse cage to bed side

Advances in gene therapy for hematologic disease and considerations for transfusion medicine

Gene Editing for the Treatment of Primary Immunodeficiency Diseases

CRISPR-Cas9 Gene Editing of Hematopoietic Stem Cells from Patients with Friedreich's Ataxia

CRISPR-CAS9. El mayor avance en técnicas de edición genética requiere una reflexión ética.

Genome editing for blood disorders: state of the art and recent advances

CIRM alpha stem cell clinics: collaboratively addressing regenerative medicine challenges

Mouse models in hematopoietic stem cell gene therapy and genome editing

Thymocyte self-renewal and oncogenic risk in immunodeficient mouse models: relevance for human gene therapy clinical trials targeting haematopoietic stem cell …

Humanized mouse models reveal an immunologic classification of idiopathic CD4 lymphocytopenia subtypes